A new study in mice hints at the potential to use tiny particles made with RNA molecules to deliver chemotherapy drugs and ...

Researchers reprogrammed bacterial bridge recombinases to edit large genomic regions in mammalian cells, revealing a ...

Scientists at Rutgers University–Newark have developed a first-of-its-kind RNA-based nanotechnology that assembles itself inside living human cells and can be programmed to stop propagation of harmful ...

International assessments show Iran ranks first in the Islamic world in gene therapy, CRISPR, RNA interference, and cell therapy, securing a leading regional scientific position.

Under the agreement, SanegeneBio has granted Genentech exclusive worldwide rights to develop and commercialize the undisclosed program.

Abstract: The selection of communication frequency band and interference suppression technology are the key factors that affect the inspection quality of unmanned aerial vehicle (UAV). The purpose of ...

After GSK’s return of Wave Life Sciences’ WVE-006 as well as the mid-stage failure of Korro Bio’s candidate, the alpha-1 ...

While the concept is well established and several RNAi drugs have reached the clinic, their effectiveness has often been limited by the challenge of delivering fragile RNA molecules intact to the ...